Ironwood Pharmaceuticals | الأصول





الأصول تغيير تاريخ
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Akebia Therapeutics USD 364.15M 18.56M 2025-09
Almirall EUR 2.31B 88.74M 2025-06
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amarin USD 659.81M 10.31M 2025-09
Ardelyx USD 486.17M 19.4M 2025-09
Astellas Pharma JPY 3.6T 153.62B 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Charles River Laboratories USD 7.51B 46.73M 2025-09
Coherus Biosciences USD 516.52M 77.05M 2025-09
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Exact Sciences USD 5.86B 39.38M 2025-12
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Lexicon Pharmaceuticals USD 225.58M 72.09M 2025-06
MacroGenics USD 270.76M 25.34M 2025-09
Moderna USD 12.34B 203M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Pacira USD 1.3B 239.68M 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Takeda JPY 15.41T 938.47B 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12


Ironwood Pharmaceuticals الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.